The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting

Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a rising incidence and a poor prognosis on conventional treatments. Surgery followed by adjuvant chemotherapy is a potentially curative option in resectable cases, while palliative-intent chemotherapy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Salati, Massimiliano, Caputo, Francesco, Baldessari, Cinzia, Carotenuto, Pietro, Messina, Marco, Caramaschi, Stefania, Dominici, Massimo, Bonetti, Luca Reggiani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517413/
https://www.ncbi.nlm.nih.gov/pubmed/34675670
http://dx.doi.org/10.2147/CMAR.S330710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517413/
https://www.ncbi.nlm.nih.gov/pubmed/34675670
http://dx.doi.org/10.2147/CMAR.S330710

Ejemplares similares